ALEXANDRIA, Va., Nov. 11 -- United States Patent no. 12,466,893, issued on Nov. 11, was assigned to Glaxo Group Ltd. (Stevenage, Great Britain).
"Antigen binding proteins" was invented by Paul Algate (Issaquah, Wash.), Stephanie Jane Clegg (Stevenage, Great Britain), Jennifer L. Craigen (Stevenage, Great Britain), Paul Andrew Hamblin (Stevenage, Great Britain), Alan Peter Lewis (Stevenage, Great Britain), Patrick Mayes (Devon, Pa.), Radha Shah Parmar (Stevenage, Great Britain) and Trevor Anthony Kenneth Wattam (Stevenage, Great Britain).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention concerns antigen binding proteins and fragments thereof which specifically bind B Cell Maturation Antigen ...